These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2407335)

  • 21. Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability than standard cytology in the diagnosis of transitional cell carcinoma of the bladder.
    Melissourgos ND; Kastrinakis NG; Skolarikos A; Pappa M; Vassilakis G; Gorgoulis VG; Salla C
    Urology; 2005 Sep; 66(3):536-41. PubMed ID: 16140073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urinary cytology in cases of bladder cancer: a critical evaluation].
    Rathert P
    Urologe A; 2003 Jul; 42(7):908-11. PubMed ID: 12898033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of urine cytology in the assessment of lower urinary tract symptoms.
    Potter JM; Quigley M; Pengelly AW; Fawcett DP; Malone PR
    BJU Int; 1999 Jul; 84(1):30-1. PubMed ID: 10444120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.
    Shariat SF; Matsumoto K; Casella R; Jian W; Lerner SP
    Eur Urol; 2005 Jul; 48(1):69-76. PubMed ID: 15967254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer.
    Lee KH
    Yonsei Med J; 2001 Feb; 42(1):14-8. PubMed ID: 11293494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced expression of a tumor-cell-derived collagenase-stimulatory factor in urothelial carcinoma: its usefulness as a tumor marker for bladder cancers.
    Muraoka K; Nabeshima K; Murayama T; Biswas C; Koono M
    Int J Cancer; 1993 Aug; 55(1):19-26. PubMed ID: 8344748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder.
    Gibanel R; Ribal MJ; Filella X; Ballesta AM; Molina R; Alcaraz A; Alcover JB
    Anticancer Res; 2002; 22(2B):1157-60. PubMed ID: 12168917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
    Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
    East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens.
    Ylagan LR; Humphrey PA
    Acta Cytol; 2001; 45(4):599-604. PubMed ID: 11480725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer.
    Wiener HG; Vooijs GP; van't Hof-Grootenboer B
    Acta Cytol; 1993; 37(2):163-9. PubMed ID: 8465635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can sensitivity of voided urinary cytology or bladder wash cytology be improved by the use of different urinary portions?
    Mungan NA; Kulacoglu S; Basar M; Sahin M; Witjes JA
    Urol Int; 1999; 62(4):209-12. PubMed ID: 10567884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of transitional cell carcinoma in bladder by intravesical injection of monoclonal antibodies.
    Chopin DK; deKernion JB
    Urol Res; 1986; 14(3):145-8. PubMed ID: 3529570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upper urinary tract washing in the diagnosis of transitional cell carcinoma of the renal pelvis and calices. A comparison with voided urine.
    Raica M; Mederle O; Ioiart I
    Rom J Morphol Embryol; 1995; 41(3-4):101-5. PubMed ID: 8772363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary cytology in the detection of bladder tumours. Influence of concomitant urothelial atypia.
    Harving N; Petersen SE; Melsen F; Wolf H
    Scand J Urol Nephrol Suppl; 1989; 125():127-31. PubMed ID: 2633311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
    Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
    J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.
    Lekili M; Sener E; Demir MA; Temeltaş G; Müezzinoğlu T; Büyüksu C
    Urol Res; 2004 May; 32(2):124-8. PubMed ID: 14685796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
    Curry JL; Wojcik EM
    Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotyping of 76 human bladder tumors with a panel of monoclonal antibodies: correlation between pathology, surface immunofluorescence and DNA content.
    Hijazi A; Devonec M; Bouvier R; Escourrou G; Longin A; Perrin P; Revillard JP
    Eur J Cancer Clin Oncol; 1989 May; 25(5):777-83. PubMed ID: 2661237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine or bladder washings in the cytologic evaluation of transitional cell carcinoma of the urinary tract. A comparison made under routine conditions supplemented by flow cytometric DNA analysis.
    Wijkström H; Lundh B; Tribukait B
    Scand J Urol Nephrol; 1987; 21(2):119-23. PubMed ID: 3616503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytologic diagnosis of transitional cell carcinoma of the urinary bladder. Comparison with endoscopical and pathological findings on 538 cases.
    Raica M; Minciu R; Miclea F; Botoca M; Drăgan P; Ioiart I
    Rom J Morphol Embryol; 1997; 43(3-4):155-61. PubMed ID: 9747115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.